Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract

NCT04617756 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma
Cancer

Interventions

DRUG: Patients receiving neoadjuvant therapy before radical nephrectomy

Sponsor

Centre Hospitalier Universitaire de Nīmes

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]